Molecules designated B7L-1
US6512095B2 · kind B2 · utility
11Cited by
1References
27Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 6, 2001 |
| Grant date | Jan 28, 2003 |
| Priority date | — |
| Expiry date | Feb 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to B7L-1 as a purified and isolated protein, the DNA encoding the B7L-1, host cells transfected with cDNAs encoding B7L-1 and processes for preparing B7L-1 polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.